Clinical impact of rapid susceptibility testing

Area of Science:

• Clinical microbiology
• Infectious disease management
• Antimicrobial stewardship

Background:

• Laboratory susceptibility testing guides antibiotic selection.
• Rapid susceptibility tests aim to improve patient outcomes and optimize antibiotic use.
• The clinical impact of these tests requires further investigation.

Purpose of the Study:

• To assess the clinical impact of susceptibility testing on antibiotic usage.
• To evaluate the effect of laboratory susceptibility testing on patient outcomes in infectious diseases.
• To compare the clinical impact of rapid versus traditional susceptibility testing methods.

Main Methods:

• Review of existing studies and clinical data.
• Analysis of the relationship between in vitro susceptibility results and clinical antibiotic use.
• Evaluation of evidence linking susceptibility testing to patient disease outcomes.

Main Results:

• In vitro susceptibility testing significantly influences antibiotic prescribing patterns.
• A direct correlation between susceptibility test results and patient outcomes is difficult to establish.
• Limited evidence supports a greater clinical impact for rapid susceptibility tests compared to overnight procedures.

Conclusions:

• Susceptibility testing is crucial for guiding antibiotic usage.
• More research is needed to definitively link susceptibility testing to improved patient outcomes.
• Routine rapid susceptibility testing should be implemented based on cost-effectiveness compared to traditional methods.